Minerva Neurosciences NERV
NASDAQ NERV
$2.47 -0.02 (-0.80%)
As of: Nov 11, 2026 · 12:20 PM EST

Minerva Neurosciences (NERV) Short-Term Debt issuances (2014)

Updated

Minerva Neurosciences (NERV) recorded Short-Term Debt issuances of $1.38 million in Q2 2014, up 176.6% from the prior quarter.

Analysis

Minerva Neurosciences (NERV) Short-Term Debt issuances (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.28 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Minerva Neurosciences 124.09 Mn -188.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 1.38 Mn
Mar 31, 2014 500,000.00
API Access

Minerva Neurosciences Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=NERV&period=max&api_key=YOUR_API_KEY